{
    "authors": [],
    "id": "SP:a61bfdb3c189791768e95ba1841ea683d8c4adcf",
    "references": [],
    "sections": [
        {
            "text": "For Peer Review Only"
        },
        {
            "heading": "Supplementary material:",
            "text": "Tables 4-11, Figures 4-6\nTable 4. Final diagnosis of non-PSC controls\nDiagnosis Number of patients\n(N=69)\nCholedocholitiasis or\ncholecystolithiasis\n16\nNo documented liver disease after\nthorough diagnostic work up\n23\nN/A 9\nAIC/AIP/IgG4 8\nAbnormal anatomy 3\nHepatitis NAS 3\nPBC 2\nAIH 2\nNAFLD 2\nCaroli\u00b4s disease 1\nN/A, not available; AIC, autoimmune cholangitis; AIP, autoimmune pancreatitis; IgG4,\nimmunoglobulin G4; PBC, primary biliary cholangitis; AIH, autoimmune hepatitis; NAFLD, nonalcoholic fatty liver disease\nPage 28 of 42\nhttp://mc.manuscriptcentral.com/gastro Email: IGAS-peerreview@journals.tandf.co.uk\nScandinavian Journal of Gastroenterology\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59\nFor Peer Review Only\nTable 5. PSC histoscore is an adjusted scoring protocol for liver histology based on the adapted Nakanuma score. (Nakanuma Y et al. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement. Pathol Int. 2010 Mar;60(3):167-74.) As an exclusion criterion for core needle biopsies, we applied the number of portal areas: under 6 portal areas in a liver biopsy specimen is considered inadequate to be evaluated. Bile duct loss, deposition of K7-positive hepatocytes and ductular reaction were analyzed from K7-stained liver biopsy specimens, whereas the inflammatory activity and the stage of fibrosis were analyzed from Herovici-stained slides due to its ability to highlight tissue collagen. Parameters of Grade - Inflammation activity\n0 1 2 3\nHepatitis activity 0\u20133\nNo activity.\nNo interface hepatitis and\nno (or\nminimal\nlobular\nhepatitis).\nMild activity.\nInterface hepatitis\naffecting 10 continuous\nhepatocytes at\nlimiting plate in 1\nportal tract (or\nfibrous septa and mild-to-moderate\nlobular activity).\nModerate activity. Interface hepatitis\naffecting 10 continuous\nhepatocytes at limiting plate in\ntwo or more\nportal tract (or\nfibrous septa and\nMarked activity.\nInterface hepatitis\naffecting 20 continuous\nhepatocytes at\nlimiting plates in\nmore than half of\nthe portal tracts\n(and moderate\nlobular hepatitis or\nPage 29 of 42\nhttp://mc.manuscriptcentral.com/gastro Email: IGAS-peerreview@journals.tandf.co.uk\nScandinavian Journal of Gastroenterology\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59\nFor Peer Review Only\nmild-to-moderate lobular hepatitis).\nbridging/zonal\nnecrosis).\nCholangitis activity 0\u20133\nNo activity.\nNo cholangitis\nbut mild\ndamage to the\nepithelium of the duct may\nbe present\nMild activity. One\nevident chronic\ncholangitis in the\nspecimen*\nModerate activity.\n2 or more bile\nducts with evident\nchronic\ncholangitis\nMarked activity.\nChronic cholangitis\nin >1/2 of portal\ntracts. **"
        },
        {
            "heading": "Portal",
            "text": "Inflammati on 0\u20133\nNo portal\ninflammation\nor a few\nlymphocytes are detected in the portal\nareas\nAt least one portal\narea has the minimum of\nmoderate\ninflammation or\nmost of the portal\nareas have the\nminimum of mild\ninflammation\nAt least two of the\nportal areas have\nthe minimum of\nmoderate\ninflammation or one portal area\nhas marked\ninflammation\nMore than half of\nthe portal areas\nhave the minimum\nof moderate\ninflammation or at\nleast two portal\nareas have marked\ninflammation"
        },
        {
            "heading": "Portal",
            "text": "oedema 0\u2013 2\nNo oedema\nLess than half of\nportal areas have\noedema\nMore than half of portal areas have\noedema\nPage 30 of 42\nhttp://mc.manuscriptcentral.com/gastro Email: IGAS-peerreview@journals.tandf.co.uk\nScandinavian Journal of Gastroenterology\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59\nFor Peer Review Only\n*We have estimated the cholangitis score as 2 when two separate portal areas have inflammatory cells among bile duct epithelium. We decided that even one clear inflammatory cell in the bile duct epithelium is considered as cholangitis. In the Nakanuma classification the score of 2 is given even if the inflamed bile ducts are located in the same portal area. **In PBC there has to be at least one florid duct lesion in the liver specimen. It was agreed that in PSC the cholangitis activity score is 3 when over half of the portal areas have bile ducts with intraepithelial inflammatory cells.\nParameters of stage - Disease progression\n0 1 2 3\nFibrosis 0\u20133\nNo portal fibrosis or fibrosis limited to portal tracts\nPortal fibrosis with periportal fibrosis or incomplete septal fibrosis\nBridging fibrosis with variable lobular disarray Liver cirrhosis with regenerative nodules and extensive fibrosis -\n> this was interpreted so that even one distinct cirrhosis nodule entitles score 3\nPage 31 of 42\nhttp://mc.manuscriptcentral.com/gastro Email: IGAS-peerreview@journals.tandf.co.uk\nScandinavian Journal of Gastroenterology\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59\nFor Peer Review Only\nBile duct loss 0\u2013 3\nNo bile duct loss\nBile duct loss in less than 1/3 of portal tracts\nBile duct loss in 1/3-2/3 of portal tracts\nBile duct loss in more than 2/3 of portal tracts"
        },
        {
            "heading": "Deposition of",
            "text": ""
        },
        {
            "heading": "K7-positive",
            "text": "hepatocytes 0\u2013 3\nNo K7 positive hepatocyt es\nK7-positivity in at least ten hepatocytes in one portal area (zone 1) K7-positivity in at least ten hepatocytes in 1/3-2/3 of portal areas\nK7-positivity in at least ten hepatocytes in more than 2/3 of portal areas\nDuctular reaction 0\u20132\nNo ductular reaction of periportal bile ducts Mild proliferation/duc tular reaction of periportal bile ducts Diffuse and/or marked reaction of periportal bile ducts\nLikelihood of PSC evaluated from a liver biopsy specimen A.\nHistological features present in the specimen Likelihood (0\u20133)\nAll histological features receive score 0 0\nPage 32 of 42\nhttp://mc.manuscriptcentral.com/gastro Email: IGAS-peerreview@journals.tandf.co.uk\nScandinavian Journal of Gastroenterology\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59\nFor Peer Review Only\nChronic cholestasis (K7 load) is scored 1-3 2\nIf any histological feature is scored above 0 1\nPericholangitis is scored 1 and chronic cholestasis is\nscored 1-3 3\nPericholangitis is scored 2 and chronic cholestasis is\nscored 0 2\nB.\nLikelihood from 0 to 3\n0\nNo histological features indicating PSC are present\n1\nHistological features seen in the biopsy specimen might be caused by PSC\n2\nHistological features seen in the biopsy specimen are likely to be caused by PSC\n3\nHistological features seen in the biopsy specimen are diagnostic for PSC\nPage 33 of 42\nhttp://mc.manuscriptcentral.com/gastro Email: IGAS-peerreview@journals.tandf.co.uk\nScandinavian Journal of Gastroenterology\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59\nFor Peer Review Only\nTable 5. Multivariate logistic regression of clinical and laboratory variables with best discrimination values for differential diagnosis and their respective scores (HelPSCreen)\nVariables Odds Ratio (95% CI) Beta (95% CI) Score*\nS-pANCIF 4.58 (2.11\u20129.91) 1.52 (0.75\u20122.29) 2\nS-ANA 1.33 (0.50\u20123.53) 0.29 (-0.69\u20121.26) -\nP-ALP 4.50 (2.39\u20128.45) 1.50 (0.87\u20122.13) 1\nP-yGT 1.63 (0.84\u20123.14) 0.49 (-0.17\u20121.14) -\nIBD 6.76 (3.62\u201212.62) 1.91 (1.29\u20122.54) 2\n*Score assigned to each statistically significant predictor regression coefficient rounded to the nearest integer pANCIF, serum atypical perinuclear antibody; ANA, serum antinuclear antibody; ALP, alkaline phosphatase; yGT, plasma gamma\u2013glutamyl transferase; IBD, inflammatory bowel disease\nTable 7. Multivariate logistic regression of clinical, laboratory and imaging (MRI/MRCP) variables with best discrimination values for differential diagnosis and their respective scores (HelPSCreen-I)\nVariables Odds Ratio (95% CI) Beta (95% CI) Score*\nS-pANCIF 4.37 (1.91\u201210.03) 1.48 (0.64\u20122.31) 1\nS-ANA 1.17 (0.42\u20123.21) 0.16 (-0.85\u20121.17) -\nPage 34 of 42\nhttp://mc.manuscriptcentral.com/gastro Email: IGAS-peerreview@journals.tandf.co.uk\nScandinavian Journal of Gastroenterology\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59\nFor Peer Review Only\nP-ALP 4.60 (2.32\u20129.12) 1.53 (0.84\u20122.21) 2\nP-yGT 2.16 (1.07\u20124.37) 0.77 (0.07\u20121.48) 1\nIBD 5.83 (3.01\u201211.30) 1.76 (1.10\u20122.42) 2\nMRI/MRCP 3.43 (1.79\u20126.57) 1.23 (0.58\u20121.88) 1\n*Score assigned to each statistically significant predictor regression coefficient rounding to nearest integer.\nTable 8. Sensitivity, specificity, positive likelihood ratio and positive predictive values for the points of the score including imaging (HelPSCreen-I)\nCut-\noff\npoint\nArea under the curve** Sensitivity Specificity Likelihood Ratio\nPositive\npredictive\nvalue\nOdds Ratio\n1 0.52\n(0.50\u20120.55)\n1.00\n(0.99\u20121.0\n0)\n0.05\n(0.01\u20120.1\n3)\n1.05\n(0.99\u20121.11)\n0.85\n(0.81\u20120.88)\n21.11\n(3.18\u2012inf.)*\n2 0.62\n(0.57\u20120.68)\n0.99\n(0.97\u20121.0\n0)\n0.26\n(0.16\u20120.3\n9)\n1.33\n(1.15\u20121.54)\n0.88\n(0.84\u20120.91)\n24.23\n(8.83\u201266.15)\nPage 35 of 42\nhttp://mc.manuscriptcentral.com/gastro Email: IGAS-peerreview@journals.tandf.co.uk\nScandinavian Journal of Gastroenterology\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59\nFor Peer Review Only\n3 0.62\n(0.57\u20120.68)\n0.99\n(0.97\u20121.0\n0)\n0.26\n(0.16\u20120.3\n9)\n1.33\n(1.15\u20121.54)\n0.88\n(0.84\u20120.91)\n24.23\n(8.83\u201266.15)\n4 0.78\n(0.72\u20120.83)\n0.80\n(0.76\u20120.8\n4)\n0.75\n(0.63\u20120.8\n5)\n3.25\n(2.12\u20125.00)\n0.95\n(0.91\u20120.97)\n12.34\n(6.65\u201222.86)\n5 0.75\n(0.70\u20120.80)\n0.62\n(0.57\u20120.6\n7)\n0.88\n(0.77\u20120.9\n5)\n5.03\n(2.62\u20129.68)\n0.96\n(0.93\u20120.98)\n11.61\n(5.45\u201224.68)\n6 0.69\n(0.65\u20120.72)\n0.40\n(0.35\u20120.4\n6)\n0.97\n(0.89\u20121.0\n0)\n13.11\n(3.33\u201251.6\n2)\n0.99\n(0.95\u20121.00)\n21.30\n(5.13\u2012>50.00)\n7 0.59\n(0.57\u20120.60)\n0.17\n(0.13\u20120.2\n1)\n1.00\n(0.94\u20121.0\n0)\n.. 1.00\n(0.94\u20121.00)\n18.91\n(4.20\u2012inf.)\n*excalogit **(Sens. + Spec.)/2\nTable 9. Multivariate logistic regression of histological variables with best discrimination values for differential diagnosis and their respective scores (HelPSCreen-H)\nHistological variable OR (95 % CI) Beta (95 % CI) Score*\nPage 36 of 42\nhttp://mc.manuscriptcentral.com/gastro Email: IGAS-peerreview@journals.tandf.co.uk\nScandinavian Journal of Gastroenterology\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59\nFor Peer Review Only\nFibrosis 8.85 (1.12\u201270.12) 2.18 (0.11\u20124.25) 2\nPortal inflammation 3.04 (1.30\u20127.12) 1.11 (0.26\u20121.96) 1\n*Score assigned to each statistically significant predictor regression coefficient rounding to nearest integer.\nTable 10. Optimal cut-off points and AUC values for histological variables (Nakanuma) for discriminating PSC from non-PSC (Suppl material?)\nOptim al cut-\noff\npoints\nAUC Sensitivit\ny\nSpecificit\ny\nLR+ Positive\npredictio\nn\nOdds Ratio\nFibrosis 2 0.65\n(0.60\u20120.6\n9)\n0.33\n(0.26\u20120.4\n0)\n0.97\n(0.85\u20121.0\n0)\n11.41\n(1.64\u201279.6\n5)\n0.98\n(0.91\u20121.0\n0)\n16.45\n(2.20\u2012123\n.07)\nPortal inflammati on\n1 0.69\n(0.61\u20120.7\n7)\n0.64\n(0.56\u20120.7\n1)\n0.74\n(0.57\u20120.8\n8)\n2.47\n(1.39\u20124.39\n)\n0.93\n(0.87\u20120.9\n7)\n5.04\n(2.26\u201211.\n21)\nPortal oedema\n1 0.54\n(0.49\u20120.6\n0)\n0.17\n(0.12\u20120.2\n3)\n0.91\n(0.77\u20120.9\n8)\n1.97\n(0.64\u20126.08\n)\n0.91\n(0.76\u20120.9\n8)\n2.16\n(0.66\u20127.0\n2)\nPage 37 of 42\nhttp://mc.manuscriptcentral.com/gastro Email: IGAS-peerreview@journals.tandf.co.uk\nScandinavian Journal of Gastroenterology\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59\nFor Peer Review Only\nHepatitis activity\n1 0.54\n(0.48\u20120.6\n0)\n0.20\n(0.15\u20120.2\n7)\n0.89\n(0.73\u20120.9\n7)\n1.76\n(0.67\u20124.62\n)\n0.90\n(0.77\u20120.9\n7)\n1.95\n(0.67\u20125.6\n1)\nPericholan gitis\n1 0.55\n(0.49\u20120.6\n1)\n0.22\n(0.16\u20120.2\n8)\n0.89\n(0.73\u20120.9\n7)\n1.90\n(0.73\u20124.98\n)\n0.91\n(0.78\u20120.9\n7)\n2.15\n(0.75\u20126.1\n7)\nCholangitis activity\n1 0.68\n(0.60\u20120.7\n7)\n0.65\n(0.58\u20120.7\n2)\n0.71\n(0.54\u20120.8\n5)\n2.28\n(1.34\u20123.89\n)\n0.92\n(0.86\u20120.9\n6)\n4.69\n(2.15\u201210.\n22)\nBile duct loss\n1 0.52\n(0.48\u20120.5\n7)\n0.10\n(0.06\u20120.1\n6)\n0.94\n(0.81\u20120.9\n9)\n1.81\n(0.44\u20127.41\n)\n0.90\n(0.70\u20120.9\n9)\n1.90\n(0.42\u201217.\n56)\nDuctulus proliferatio n\n1 0.65\n(0.56\u20120.7\n3)\n0.55\n(0.47\u20120.6\n2)\n0.74\n(0.57\u20120.8\n8)\n2.14\n(1.20\u20123.81\n)\n0.92\n(0.85\u20120.9\n6)\n3.52\n(1.59\u20127.8\n1)\nChronic cholestasis\n1 0.63\n(0.56\u20120.7\n0)\n0.40\n(0.33\u20120.4\n8)\n0.86\n(0.70\u20120.9\n5)\n2.81\n(1.22\u20126.44\n)\n0.94\n(0.86\u20120.9\n8)\n4.02\n(1.53\u201210.\n47)\nTable 11. Optimal cut-off points and AUC values for Nakanuma score for discriminating PSC from non-PSC.\nPage 38 of 42\nhttp://mc.manuscriptcentral.com/gastro Email: IGAS-peerreview@journals.tandf.co.uk\nScandinavian Journal of Gastroenterology\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59\nFor Peer Review Only\nOptimal\ncut-off points\nAUC Sen Spe LR+ Positive\npredictio\nn\nOdds Ratio\nNakanu ma total score\n2 0.68\n(0.62\u20120.7\n5)\n0.48\n(0.41\u20120.5\n6)\n0.89\n(0.73\u20120.97\n)\n4.23\n(1.66\u201210.\n77)\n0.96\n(0.89\u20120.9\n9)\n7.26\n(2.56\u201220.\n47)\nNakanu ma\nGrade 1 0.69\n(0.61\u20120.7\n7)\n0.66\n(0.59\u20120.7\n3)\n0.71\n(0.54\u20120.85\n)\n2.32\n(1.36\u20123.9\n6)\n0.92\n(0.87\u20120.9\n6)\n4.92\n(2.25\u201210.\n73)\nStage 3 0.60\n(0.57\u20120.6\n3)\n0.20\n(0.14\u20120.2\n6)\n1.00\n(0.90\u20121.00\n)\n1.00\n(0.90\u20121.0\n0)\n1.00\n(0.90\u20121.0\n0)\n..\nPage 39 of 42\nhttp://mc.manuscriptcentral.com/gastro Email: IGAS-peerreview@journals.tandf.co.uk\nScandinavian Journal of Gastroenterology\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59\nFor Peer Review Only\nFigure 4. PSC: screening and diagnosis\nPage 40 of 42\nhttp://mc.manuscriptcentral.com/gastro Email: IGAS-peerreview@journals.tandf.co.uk\nScandinavian Journal of Gastroenterology\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59\nFor Peer Review Only\nFigure 5. AUC and Optimal cut-off and AUC of value for diagnosis of PSC (HelPSCreen-I score) based on laboratory data, history of IBD and MRCP\nPage 41 of 42\nhttp://mc.manuscriptcentral.com/gastro Email: IGAS-peerreview@journals.tandf.co.uk\nScandinavian Journal of Gastroenterology\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59\nFor Peer Review Only\nFigure 6A. Bar chart showing number of patients according to score (HelPSCreen-I) points (total) and those with confirmed PSC diagnosis (grey bars) and non-PSC controls (white bars).\nPage 42 of 42\nhttp://mc.manuscriptcentral.com/gastro Email: IGAS-peerreview@journals.tandf.co.uk\nScandinavian Journal of Gastroenterology\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59"
        }
    ],
    "year": 2023
}